EDGAR·FLOW

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. — Form 8-K

Filed September 25, 2026 · analyzed by the 8-K Agent
8-K — Neutral significance 72/100
What the filing says
Creative Medical Technology Holdings (CMTH) purchased 4,000,000 shares of BioDefense, Inc. common stock from Creative Acquisition Corp. on September 24, 2026. Consideration: $200,000 cash plus 1,000,000 CMTH shares (unspecified valuation). Post-closing: CMTH owns 16M BioDefense shares (67% of transaction 4M shares); seller retains 4M shares.
Why this rating

Acquisition cost ~$200K cash is 4% of CMTH's $4.6M market cap; issuance of 1M new shares dilutes existing shareholders but valuation not disclosed. Material but unproven strategic value in undisclosed target company.

Price action (we called it neutral)
before filing · preread
$0.98 ▼ 4.78%
at our read · unknown
$1.03
+10 min · unknown
$0.98 ▼ 4.85%
+30 min · unknown
$0.98 ▼ 4.47%
+1 hr · unknown
$1.02 ▼ 0.97%
+4 hrs · unknown
$1.02 ▼ 0.97%

The stock had already moved +5.02% between hitting EDGAR and our read finishing — deltas above are measured from our read.

Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →

View original filing on SEC.gov ↗ CELZ · stock on Yahoo Finance ↗

See more from September 25, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.